| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT06589596 An Investigational Study of BGB-58067 As a Single Agent and in Combination With… |
Trial sites expanded: 82 -> 87 locations |
| 2026-05-15 | NCT07485049 BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors |
Recruitment opened |
| 2026-05-15 | NCT07485049 BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors |
date change Primary completion pushed: 2027-04 -> 2027-11 |
| 2026-05-15 | NCT07485049 BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors |
date change Completion pushed: 2028-04 -> 2028-11 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-15 | NCT07590102 A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT06589596 | An Investigational Study of BGB-58067 As a Single Agent and in Combination With… | Advanced Solid Tumor | Recruiting |
| NCT07590102 | A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor… | Healthy Volunteers | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT07485049 | BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors | Glioblastoma (GBM) | Recruiting |